Clinical Trial Update: Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating plerixafor with G-CSF plus busulfan, fludarabine, and thymoglobulin for stem cell transplantation in leukemia patients; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Stem Cell Transplantation

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
• Plerixafor (Plerixafor)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stem Cell Transplantation, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-07-16